Cara Total Revenue from 2010 to 2024
| CARA Stock | USD 0.78 0.01 1.30% |
Total Revenue | First Reported 2011-12-31 | Previous Quarter 4.9 M | Current Value 3 M | Quarterly Volatility 16.7 M |
Check Cara Therapeutic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cara main balance sheet or income statement drivers, such as Depreciation And Amortization of 498.1 K, Interest Expense of 1 M or Selling General Administrative of 15.7 M, as well as many exotic indicators such as Price To Sales Ratio of 1.82, Dividend Yield of 0.0 or PTB Ratio of 0.67. Cara financial statements analysis is a perfect complement when working with Cara Therapeutic Valuation or Volatility modules.
Cara | Total Revenue |
Latest Cara Therapeutic's Total Revenue Growth Pattern
Below is the plot of the Total Revenue of Cara Therapeutic over the last few years. Total revenue comprises all receipts Cara Therapeutic generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Cara Therapeutic's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cara Therapeutic's overall financial position and show how it may be relating to other accounts over time.
| Total Revenue | 10 Years Trend |
|
Total Revenue |
| Timeline |
Cara Total Revenue Regression Statistics
| Arithmetic Mean | 20,203,923 | |
| Geometric Mean | 5,885,786 | |
| Coefficient Of Variation | 168.54 | |
| Mean Deviation | 19,356,430 | |
| Median | 11,964,000 | |
| Standard Deviation | 34,052,544 | |
| Sample Variance | 1159.6T | |
| Range | 135M | |
| R-Value | 0.46 | |
| Mean Square Error | 987.1T | |
| R-Squared | 0.21 | |
| Significance | 0.09 | |
| Slope | 3,485,635 | |
| Total Sum of Squares | 16234.1T |
Cara Total Revenue History
About Cara Therapeutic Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cara Therapeutic income statement, its balance sheet, and the statement of cash flows. Cara Therapeutic investors use historical funamental indicators, such as Cara Therapeutic's Total Revenue, to determine how well the company is positioned to perform in the future. Although Cara Therapeutic investors may use each financial statement separately, they are all related. The changes in Cara Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cara Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cara Therapeutic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cara Therapeutic. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 21 M | 25.2 M |
Pair Trading with Cara Therapeutic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cara Therapeutic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will appreciate offsetting losses from the drop in the long position's value.Moving together with Cara Stock
| 0.63 | TPDDF | Talon Energy | PairCorr |
Moving against Cara Stock
| 0.81 | GSTX | Graphene Solar Techn | PairCorr |
| 0.75 | IRNRF | Iron Road Limited | PairCorr |
| 0.51 | IMHC | Imperalis Holding Corp | PairCorr |
| 0.49 | SRBBF | VPN Technologies | PairCorr |
The ability to find closely correlated positions to Cara Therapeutic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cara Therapeutic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cara Therapeutic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cara Therapeutic to buy it.
The correlation of Cara Therapeutic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cara Therapeutic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cara Therapeutic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cara Therapeutic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cara Therapeutic Correlation against competitors. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.387 | Quarterly Revenue Growth (0.08) | Return On Assets (0.49) | Return On Equity (1.10) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.